EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chemotherapy modulation by a cancer-associated microbiota metabolite

Daniel Martinez-Martinez, Tanara V Peres, Kristin Gehling, Leonor Quintaneiro, Cecilia Cabrera, Maksym Cherevatenko, Stephen J Cutty, Lena Best, Georgios Marinos, Johannes Zimmerman, Ayesha Safoor, Despoina Chrysostomou und 17 weitere

Cell Systems · 2025

DOI: 10.1016/j.cels.2025.101397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Systems, 2025. Verfasst von Daniel Martinez-Martinez und 28 weiteren Autor:innen. Beteiligte Einrichtung: MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0HS, UK; Institute of Clinical Sciences, Imperial College London, Hammersmith Hosp…. Hauptthemen laut MEDLINE: Neoplasms, Microbiota, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Office of Research Infrastructure Programs, Deutsche Forschungsgemeinschaft, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding how the microbiota produces regulatory metabolites is of significance for cancer and cancer therapy. Using a host-microbe-drug-nutrient 4-way screening approach, we evaluated the role of nutrition at the molecular level in the context of 5-fluorouracil toxicity. Notably, our screens identified the metabolite 2-methylisocitrate, which was found to be produced and enriched in human tumor-associated microbiota. 2-methylisocitrate exhibits anti-proliferative properties across genetically and tissue-diverse cancer cell lines, three-dimensional (3D) spheroids, and an in vivo Drosophila gut tumor model, where it reduced tumor dissemination and increased survival. Chemical landscape interaction screens identified drug-metabolite signatures and highlighted the synergy between 5-fluorouracil and 2-methylisocitrate. Multi-omic analyses revealed that 2-methylisocitrate acts via multiple cellular pathways linking metabolism and DNA damage to regulate chemotherapy. Finally, we converted 2-methylisocitrate into its trimethyl ester, thereby enhancing its potency. This work highlights the great impact of microbiome-derived metabolites on tumor proliferation and their potential as promising co-adjuvants for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMicrobiotaAntineoplastic AgentsHumansAnimalsFluorouracilCell ProliferationCell Line, TumorGastrointestinal Microbiome

Stichwörter der Autor:innen

cancer metabolismcancer-associated microbiotachemotherapyhost-microbe interactionsmethylcitrate cyclemicrobial metabolism

Substanzen

FluorouracilAntineoplastic Agents

Autor:innen und Institutionen

  • MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0HS, UK; Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0HS, UK.
  • University of Cologne, Faculty of Mathematics and Natural Sciences, Institute of Genetics, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany.
  • Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0HS, UK.
  • University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute for Metabolomics in Ageing, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany.
  • Institute for Experimental Medicine, Kiel University, Kiel 24105, Germany.
  • Division of Digestive Diseases, Faculty of Medicine, Imperial College London, London W12 0NN, UK.

Förderung

  • Office of Research Infrastructure Programs
  • Deutsche Forschungsgemeinschaft
  • Wellcome Trust
  • Center for Molecular Medicine Cologne, University of Cologne
  • School of Medicine, Johns Hopkins University
  • Royal Society
  • UK Research and Innovation Medical Research Council
  • Leverhulme Trust

Zitieren

APA

Martinez-Martinez, D., Peres, T. V., Gehling, K., Quintaneiro, L., Cabrera, C., Cherevatenko, M., Cutty, S. J., Best, L., Marinos, G., Zimmerman, J., Safoor, A., Chrysostomou, D., Mokochinski, J. B., Montoya, A., Brodesser, S., Zatorska, M., Scott, T., Andrew, I., Kramer, H., …, & Cabreiro, F. (2025). Chemotherapy modulation by a cancer-associated microbiota metabolite. Cell Systems. https://doi.org/10.1016/j.cels.2025.101397

Vancouver

Martinez-Martinez D, Peres TV, Gehling K, Quintaneiro L, Cabrera C, Cherevatenko M, et al. Chemotherapy modulation by a cancer-associated microbiota metabolite. Cell Systems. 2025. doi:10.1016/j.cels.2025.101397

BibTeX
@article{MartinezMartinez2025,
  author = {Martinez-Martinez, Daniel and Peres, Tanara V and Gehling, Kristin and Quintaneiro, Leonor and Cabrera, Cecilia and Cherevatenko, Maksym and Cutty, Stephen J and Best, Lena and Marinos, Georgios and Zimmerman, Johannes and Safoor, Ayesha and Chrysostomou, Despoina and Mokochinski, Joao B and Montoya, Alex and Brodesser, Susanne and Zatorska, Michalina and Scott, Timothy and Andrew, Ivan and Kramer, Holger and Begum, Masuma and Zhang, Bian and Golding, Bernard T and Marchesi, Julian R and Hirabayashi, Susumu and Kaleta, Christoph and Barr, Alexis R and Frezza, Christian and Cochemé, Helena M and Cabreiro, Filipe},
  title = {Chemotherapy modulation by a cancer-associated microbiota metabolite},
  journal = {Cell Systems},
  year = {2025},
  doi = {10.1016/j.cels.2025.101397}
}
Kostenlos starten →